Adverse effects by frequency:<ref name = AMH/><ref name = MSR>{{cite web|title=Dovonex, Calcitrene Ointment (calcipotriene) dosing, indications, interactions, adverse effects, and more|work=Medscape Reference|publisher=WebMD|accessdate=26 January 2014|url=http://reference.medscape.com/drug/dovonex-calcipotriene-topical-343541#showall}}</ref><ref name = DM>{{cite web|title=CALCIPOTRIENE (calcipotriene) solution [E. FOUGERA & CO. A division of Fougera Pharmaceuticals Inc.]|work=DailyMed|publisher=E. FOUGERA & CO. A division of Fougera Pharmaceuticals Inc.|date=May 2012|accessdate=26 January 2014|url=http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=fff63bc7-6b92-4080-9a11-017124d95162}}</ref><ref name = TGA>{{cite web|title=PRODUCT INFORMATION DAIVONEX® CREAM Calcipotriol 50 microgram/g|work=TGA eBusiness Services|publisher=LEO Pharma Pty Ltd|date=28 April 2011|accessdate=26 January 2014|url=https://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent&id=CP-2011-PI-02886-3|format=PDF}}</ref>

 
;Very common (> 10% frequency):

 
* Burning

 
* Itchiness

 
* Skin irritation

 


 
;Common (1–10% frequency):

 
{{colbegin|4}}

 
* [[Dermatitis]]

 
* Dry skin

 
* [[Erythema]]

 
* Peeling

 
* Worsening of psoriasis including facial/scalp

 
* Rash

 
{{colend}}

 


 
;Uncommon (0.1–1% frequency):

 
* Exacerbation of [[psoriasis]]

 


 
;Rare (< 0.1% frequency):

 
{{colbegin|4}}

 
* Allergic contact dermatitis

 
* [[Hypercalcaemia]]

 
* [[Photosensitivity]]

 
* Changes in pigmentation

 
* Skin atrophy

 
{{colend}}

 

